Microbot Medical (MBOT) Cost of Revenue (2010 - 2026)

Microbot Medical's (MBOT) quarterly Cost of Revenue came in at $103000.0 in Q1 2026, up 77.09% on a QoQ basis from $58163.0 in Q3 2014.

Microbot Medical (MBOT) Cost of Revenue (2010 - 2026) Analysis & Trends

Microbot Medical (MBOT) has 6 years of Cost of Revenue data on file, last reported at $103000.0 in Q1 2026.

Quarterly Cost of Revenue changed N/A year-over-year to $103000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $326536.0 (changed N/A YoY) and the FY2025 annual result came in at $171000.0, down 3.93% from the prior year.
Cost of Revenue rose to $103000.0 in Q1 2026, from $58163.0 in the prior quarter.
In the past five years, Cost of Revenue ranged from a high of $103000.0 in Q1 2026 to a low of $103000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cost of Rev (Qtr)
1	Intuitive Surgical	134.13 Bn	128.91 Bn	1.96 Bn	931.90 Mn
2	Becton Dickinson	52.76 Bn	51.90 Bn	2.32 Bn	2.67 Bn
3	Alcon	35.81 Bn	34.46 Bn	1.68 Bn	1.13 Bn
4	Resmed	33.72 Bn	32.25 Bn	861.22 Mn	602.43 Mn
5	Medline	29.38 Bn	26.70 Bn	2.22 Bn	5.47 Bn
6	West Pharmaceutical Services	25.00 Bn	24.57 Bn	329.20 Mn	543.10 Mn
7	Solventum	15.46 Bn	15.06 Bn	1.29 Bn	807.00 Mn
8	Cooper Companies	14.88 Bn	14.74 Bn	735.40 Mn	346.10 Mn
9	Baxter International	13.58 Bn	11.43 Bn	1.03 Bn	1.93 Bn
10	Microbot Medical	101.07 Mn	101.07 Mn	2,000.00	103,000.00

Download Data